Investing in data enabled and technology scaled companies at the intersection of health, tech, and bio to create the next generation of healthcare innovations
There is a funding gap and a market opportunity for companies at the Series A stage that operate at the intersection of health, technology, and drug discovery. We aim to solve that need.
